Global Platinum based Cancer Drug Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
- 146775
- 12-Aug
- Pharmaceutical
- 110
- MRR
-
Report Details
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development. Addition of platinum-based chemotherapy drugs to chemoradiation in women with early cervical cancer seems to improve survival and reduce risk of recurrence. In total, these drugs can cause a combination of more than 40 specific side effects which include neurotoxicity, which is manifested by peripheral neuropathies including polyneuropathy. Based on the Platinum based Cancer Drug market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on. In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term. In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels. In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government. Key players in the global Platinum based Cancer Drug market covered in Chapter 5: Hengrui Medicine Pfizer SK Chemicals Yi Bai Pharmaceutical Dr Reddy?s Laboratories Sun Pharma Qilu Pharmaceutical Mylan Teva ASK Pharma Debiopharm Novartis Accord Healthcare Sanofi In Chapter 6, on the basis of types, the Platinum based Cancer Drug market from 2015 to 2025 is primarily split into: Cisplatin Oxaliplatin Carboplatin Other In Chapter 7, on the basis of applications, the Platinum based Cancer Drug market from 2015 to 2025 covers: Colorectal cancer Ovarian cancer Lung cancer Other Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13: North America (Covered in Chapter 9) United States Canada Mexico Europe (Covered in Chapter 10) Germany UK France Italy Spain Russia Others Asia-Pacific (Covered in Chapter 11) China Japan South Korea Australia India South America (Covered in Chapter 12) Brazil Argentina Columbia Middle East and Africa (Covered in Chapter 13) UAE Egypt South Africa Years considered for this report: Historical Years: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Period: 2020-2025
-
Table Of Content
Table of Content 1 Market Overview 1.1 Product Definition and Market Characteristics 1.2 Global Platinum based Cancer Drug Market Size 1.3 Market Segmentation 1.4 Global Macroeconomic Analysis 1.5 SWOT Analysis 2. Market Dynamics 2.1 Market Drivers 2.2 Market Constraints and Challenges 2.3 Emerging Market Trends 2.4 Impact of COVID-19 2.4.1 Short-term Impact 2.4.2 Long-term Impact
-
Inquiry Before Buying
-
Request Sample